ArticleBMJ oncology2023

Nivolumab in salivary gland cancers: confronting the challenges of unlocking the therapeutic benefits of immunotherapy for rare diseases.

Antoine Desilets et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.